Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Dermatologic Training and Practice in Canada: A Historical Overview.

Mydlarski PR, Parsons LM, Pierscianowski TA, Humphrey S, Kirchhof MG, Powell J, Rosen CF, Huck E, Conway J, Kouri A.

J Cutan Med Surg. 2019 May/Jun;23(3):307-318. doi: 10.1177/1203475419840630. Epub 2019 Apr 18.

PMID:
30999785
2.

Skin cancer knowledge and photoprotective practices of organ transplant recipients.

Traboulsi D, Potok OV, Ruzycki SM, Surmanowicz P, Hardin J, Khokhar B, Rabi DM, Hazlewood G, Mydlarski PR.

Clin Transplant. 2019 May;33(5):e13524. doi: 10.1111/ctr.13524. Epub 2019 Apr 6.

PMID:
30860618
3.

Morphea associated with primary biliary cirrhosis and Waldenstrom macroglobulinemia: Response to rituximab.

Traboulsi D, Kaminska EA, Barr SG, Hunter C, Mydlarski PR.

JAAD Case Rep. 2018 Sep 14;4(8):784-787. doi: 10.1016/j.jdcr.2018.04.016. eCollection 2018 Sep. No abstract available.

4.

Plasmablasticlike lymphoma arising within chronic pyoderma gangrenosum.

Dupuis E, Zarbafian M, Asgarpour J, Parsons L, Mydlarski PR.

JAAD Case Rep. 2017 Apr 14;3(3):200-201. doi: 10.1016/j.jdcr.2017.02.005. eCollection 2017 May. No abstract available.

5.

Burnout in dermatology residents: a Canadian perspective.

Shoimer I, Patten S, Mydlarski PR.

Br J Dermatol. 2018 Jan;178(1):270-271. doi: 10.1111/bjd.15549. Epub 2017 Nov 1. No abstract available.

PMID:
28374946
6.

Dermatologic uses of omalizumabtitle.

Chia JC, Mydlarski PR.

J Dermatolog Treat. 2017 Jun;28(4):332-337. doi: 10.1080/09546634.2016.1249819. Epub 2016 Nov 7. Review.

PMID:
27759482
7.

Incidence of melanoma in organ transplant recipients in Alberta, Canada.

Tran M, Sander M, Ravani P, Mydlarski PR.

Clin Transplant. 2016 Oct;30(10):1271-1275. doi: 10.1111/ctr.12818. Epub 2016 Sep 23.

PMID:
27448204
8.

Sirolimus: a therapeutic advance for dermatologic disease.

Peters T, Traboulsi D, Tibbles LA, Mydlarski PR.

Skin Therapy Lett. 2014 Jul-Aug;19(4):1-4.

9.

Toll-like receptors: role in dermatological disease.

Hari A, Flach TL, Shi Y, Mydlarski PR.

Mediators Inflamm. 2010;2010:437246. doi: 10.1155/2010/437246. Epub 2010 Aug 22.

10.

Systemic retinoids: chemoprevention of skin cancer in transplant recipients.

Hardin J, Mydlarski PR.

Skin Therapy Lett. 2010 Jul-Aug;15(7):1-4. Review.

11.

Prevalence of non-organ-specific autoantibodies in patients with pemphigus vulgaris.

Blondin DA, Zhang Z, Shideler KK, Hou H, Fritzler MJ, Mydlarski PR.

J Cutan Med Surg. 2009 Mar-Apr;13(2):82-7.

PMID:
19298776
12.

Painless pink papules with central porcelain-white scars.

Mydlarski PR, Barber DF, Robertson LH.

CMAJ. 2008 Nov 18;179(11):1171-3. doi: 10.1503/cmaj.080373. No abstract available.

13.

Dermacase. Tinea versicolor.

Prajapati V, Mydlarski PR.

Can Fam Physician. 2008 Nov;54(11):1557-8. No abstract available.

14.

GW bodies: cytoplasmic compartments in normal human skin.

Zee JM, Shideler KK, Eystathioy T, Bruecks AK, Fritzler MJ, Mydlarski PR.

J Invest Dermatol. 2008 Dec;128(12):2909-12. doi: 10.1038/jid.2008.154. Epub 2008 Jun 12. No abstract available.

15.

Advances in pemphigus therapy.

Prajapati V, Mydlarski PR.

Skin Therapy Lett. 2008 Apr;13(3):4-7. Review.

16.

Dermacase. Pretibial myxedema.

Prajapati VH, Mydlarski PR.

Can Fam Physician. 2008 Mar;54(3):357, 369. No abstract available.

17.

Rituximab: a B-cell depletion therapy for dermatologic disease.

Prajapati V, Mydlarski PR.

Skin Therapy Lett. 2007 Jul-Aug;12(6):6-9. Review.

18.

Effect of intravenous immunoglobulin on prednisone dose in patients with pemphigus vulgaris.

Mittmann N, Chan B, Knowles S, Mydlarski PR, Cosentino L, Shear N.

J Cutan Med Surg. 2006 Sep-Oct;10(5):222-7.

PMID:
17234105
19.

Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.

Mydlarski PR, Ho V, Shear NH.

J Cutan Med Surg. 2006 Sep-Oct;10(5):205-21.

PMID:
17234104
20.

Mycophenolate mofetil: a dermatologic perspective.

Mydlarski PR.

Skin Therapy Lett. 2005 Apr;10(3):1-6.

21.

Bullous pemphigoid: from bench to bedside.

Walsh SR, Hogg D, Mydlarski PR.

Drugs. 2005;65(7):905-26. Review.

PMID:
15892587
22.

Intravenous immunoglobulin: use in dermatology.

Mydlarski PR, Mittmann N, Shear NH.

Skin Therapy Lett. 2004 May;9(5):1-6. Review.

23.

Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.

Tavadia SM, Mydlarski PR, Reis MD, Mittmann N, Pinkerton PH, Shear N, Sauder DN.

J Am Acad Dermatol. 2000 Apr;42(4):628-32.

PMID:
10727309

Supplemental Content

Loading ...
Support Center